Novartis taps Bicycle to develop radiopharmaceutical drugs for cancer
BioPharma
Source: biopharmadive.com
Stay updated with breaking news from Jonathan Chang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good afternoon. We will begin the MacroGenics 2022 Fourth Quarter Corporate Progress and Financial Results Conference Call in just a moment.
MGNX earnings call for the period ending December 31, 2022.
Operator: Good day, and thank you for standing by. Welcome to the Revolution Medicines Q4 Year-End 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Operator: Good morning, and welcome to Mersana Therapeutics Fourth Quarter and Year End 2022 Conference Call and Webcast. Currently, all participants are in a listen-only mode.